Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q04DX005 (ip) |
median survival time |
saline |
0.52 mg/kg/injection |
101.0 |
Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
Q04DX005 (ip) |
median survival time |
saline |
0.86 mg/kg/injection |
104.0 |
Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
Q04DX005 (ip) |
median survival time |
saline |
1.44 mg/kg/injection |
97.0 |
Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
Q04DX005 (ip) |
median survival time |
saline |
2.4 mg/kg/injection |
97.0 |
Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
Q04DX005 (ip) |
median survival time |
saline |
4.0 mg/kg/injection |
96.0 |
Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |
Q04DX005 (ip) |
median survival time |
saline |
6.67 mg/kg/injection |
99.0 |
Antitumor endpoint evaluated on day 90; 10/10 animals surviving on day 9 |